Compare Mitra International Resources Tbk. (MIRA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitra International Resources Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mitra International Resources Tbk. trades at Rp25 (market cap 103B, 7.29M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mitra International Resources Tbk. and Organon Pharma Indonesia Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| MIRA | SCPI | |
|---|---|---|
Market Cap | 103B | 104.4B |
Volume | 7.29M | — |
Lot | 72.9K | — |
Turnover | 182.24M | — |
Average Price | 25 | — |
Value | 182.24M | — |
Indicative Equilibrium Price | 25 | — |
Indicative Equilibrium Volume | 10K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitra International Resources Tbk.
PT Mitra International Resources Tbk formerly PT Mitra Rajasa was established based on Deed No.285 dated April 24, 1979 of Ridwan Suselo, SH., a public notary in Jakarta, and operates as a trucking enterprise. The company started out with 20 trucks carrying cement for Indocement to all parts of Java.
Read more on MIRA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
